2025-11-16 - Analysis Report
Okay, let's analyze Intuitive Surgical (ISRG) based on the data provided.

**Report on Intuitive Surgical (ISRG)**

Intuitive Surgical Inc. designs, manufactures, and markets robotic surgical systems and related instruments and accessories.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return (ISRG):** 98.18%
*   **Cumulative Return (VOO):** 98.45%
*   **Absolute Deviation:** -0.27% (ISRG underperforms VOO by 0.27% in cumulative return)
*   **Deviation Range:** Max: 98.9, Min: -37.8
*   **Relative Deviation:** 29.3 (This indicates that the current deviation is in the lower range of its historical deviation.)

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
| :----------- | :----- | :----- | :------ | :----- | :------- |
| 2015-2017  | 68.0%  | 77.6%  | 41.0%   | -0.1   | 44.4     |
| 2016-2018  | 64.0%  | 72.2%  | 48.0%   | -0.0   | 58.2     |
| 2017-2019  | 54.0%  | 72.2%  | 31.0%   | 0.2   | 71.9     |
| 2018-2020  | -6.0%  | 80.4%  | -29.0%  | 0.2    | 99.5     |
| 2019-2021  | 29.0%  | 80.4%  | -18.0%  | 0.5    | 131.1    |
| 2020-2022  | -23.0% | 80.4%  | -22.0%  | 1.2    | 96.8     |
| 2021-2023  | -17.0% | 77.5%  | -18.0%  | 1.7    | 123.1    |
| 2022-2024  | 36.0%  | 77.5%  | 15.0%   | 1.7    | 190.4    |
| 2023-2025  | 60.0%  | 72.7%  | -3.0%   | 0.8    | 200.5    |

*   **CAGR Trends:** The CAGR shows significant volatility over different periods, ranging from negative to very high growth.
*   **Alpha:** Alpha is inconsistent, indicating periods of both outperformance and underperformance relative to its benchmark.  Recent years show improved Alpha figures.
*   **Beta:** Beta values have generally increased over time, particularly in recent years. A beta greater than 1 suggests the stock is more volatile than the market.
*   **Market Cap:** Intuitive Surgical is a large-cap company, with capitalization consistently growing over time.

**2. Recent Stock Price Movement**

*   **Current Price:** $549.51
*   **Previous Close:** $565.51
*   **Change:** -2.83% (Significant drop from previous close)
*   **5-day Moving Average:** $567.17
*   **20-day Moving Average:** $540.99
*   **60-day Moving Average:** $479.90

The current price is below the 5-day moving average but above the 20-day and 60-day moving averages, indicating a potential short-term downward trend but a longer-term upward trend. The significant drop from the previous close (-2.83%) suggests some recent negative market reaction.

**3. Market Risk Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommendation)
*   **RSI:** 49.19 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.23 (Negative, suggesting a slight downward trend)
*   **Hybrid Signal:** Buy 100% of cash (2 shares) with monthly investment of 0.8% of total investment.
*   **Recent Change in Relative Deviation:** +3.8 (Positive, indicating a short-term increase)
*   **Expected Return:** 29.1% (Projected excess return over the S&P 500 for long-term investment)

The MRI suggests a medium level of investment risk. The positive change in relative deviation indicates some recent improvement. The expected return is quite optimistic, suggesting potential for significant outperformance in the long run. The Hybrid Signal is recommending to buy.

**4. Recent News & Significant Events**

*   Several articles discuss Intuitive Surgical's valuation and potential upside after earnings. Some question whether the valuation is limiting further growth.
*   One article highlights a significant stock increase since October lows after a strong earnings turnaround.
*   Another article questions whether it's time to sell shares of ISRG.
*   Argus Research gives a bullish technical assessment in the intermediate term.
*   Multiple reports indicate recent insider selling of shares worth significant amounts.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean of 2.00)
*   **Opinions:** 29 analysts
*   **Target Price:** Average: $592.96, High: $700.00, Low: $378.00
*   **Recent Rating Changes:** Not specified in provided data

The analyst consensus is positive, with a buy rating and a substantial average target price above the current price.  However, the wide range of target prices suggests differing opinions among analysts.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue    |
| :----------- | :--- | :---------- |
| 2025-10-22 | 1.98 | 2.51 B\$   |
| 2025-07-23 | 1.84 | 2.44 B\$   |
| 2025-04-23 | 1.95 | 2.25 B\$   |
| 2024-10-18 | 1.59 | 2.04 B\$   |
| 2025-10-22 | 1.59 | 2.04 B\$   |

Earnings per share (EPS) and revenue have generally increased over the most recent quarters, suggesting strong financial performance.  The most recent data point shows EPS at 1.98 and Revenue at 2.51 B\$.

**6. Financial Information**

| Quarter    | Revenue  | Profit Margin |
| :----------- | :-------- | :-------------- |
| 2025-09-30 | \$2.51B  | 66.36%        |
| 2025-06-30 | \$2.44B  | 66.31%        |
| 2025-03-31 | \$2.25B  | 64.69%        |
| 2024-12-31 | \$2.41B  | 68.04%        |
| 2024-09-30 | \$2.04B  | 67.41%        |

Revenue and profit margins have been strong and generally increasing over the last several quarters.

| Quarter    | Equity   | ROE     |
| :----------- | :--------- | :------- |
| 2025-09-30 | \$16.93B | 4.16%  |
| 2025-06-30 | \$17.85B | 3.69%  |
| 2025-03-31 | \$17.11B | 4.08%  |
| 2024-12-31 | \$16.43B | 4.17%  |
| 2024-09-30 | \$15.58B | 3.63%  |

Equity is strong, and Return on Equity (ROE) has been relatively stable.

**7. Overall Analysis**

Intuitive Surgical presents a mixed picture.

*   **Positives:** Strong recent earnings and revenue growth, healthy profit margins, positive long-term expected return, buy consensus from analysts, bullish technical assessment. MRI indicator suggests medium investment.
*   **Negatives:** Recent stock price drop, slight underperformance vs. S&P 500, high volatility (as indicated by Beta), insider selling, some analyst concern over valuation.

**Recommendation:**

The recent price drop and insider selling warrant caution. However, the strong financial performance, positive analyst sentiment, and high expected return suggest that Intuitive Surgical may be a worthwhile long-term investment, particularly if the price stabilizes. A "buy and hold" strategy with incremental purchases during dips could be considered. However, investors should carefully monitor the news and financial reports for any further negative developments. Also, consider the hybrid signal's recommendation to buy. The MRI indicator also suggests that this is medium level of investment so not very risky decision.
